See the market from the prescribers’ point of view.
Our physician community includes direct relationships with our curated physician network and leading KOLs, who keep us closely connected with the specific challenges of specialty markets.
Vetted Practicing Physicians
Key Opinion Leaders
Professional Organizations
3,300+
members in the Spherix US Physician Community
We are your thought partners.
We are dedicated to the life sciences therapeutic areas we cover:
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Gianna has been with Spherix since 2017. Prior to Spherix, Gianna received her master’s degree in experimental psychology from Saint Joseph’s University. She previously worked at the University of Pennsylvania conducting clinical trials focusing on women’s health.
Sign up for alerts, market insights and
exclusive content in your inbox.
Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:
HEMATOLOGY
Throughout 2024, we will be publishing over 10 groundbreaking studies covering a wide range of indications within classical hematology.